| HIPAA and HITECH | US healthcare, life sciences and their business associates | Sensitivity labels and encryption for PHI, DLP, audit logging, access reviews, retention |
| FDA 21 CFR Part 11 and GxP | Pharmaceutical, biotech and medical device | Controlled document versioning, approval workflows, audit trails, e-signature, validation evidence |
| SOX | US public companies | Privileged access, change control, retention of financial records, access certification |
| SEC 17a-4 and FINRA recordkeeping | Broker-dealers and investment firms | Immutable retention (preservation lock), communication compliance, eDiscovery |
| GLBA and NYDFS 23 NYCRR 500 | Banks, insurers and financial services | MFA, encryption, logging, incident response, third-party access controls |
| NIST CSF, NIST SP 800-171 and CMMC | Federal contractors and organizations adopting NIST | Identity, device compliance, CUI labeling, audit, incident response |
| CCPA/CPRA and US state privacy laws | Organizations handling consumer personal data | Data discovery, subject rights requests, retention and deletion |
| Bermuda Monetary Authority (BMA) | Bermuda insurers, reinsurers and other BMA-regulated entities | Operational Cyber Risk Management Code of Conduct controls (governance, identity, protection, detection, response, third-party risk), outsourcing and cloud oversight evidence, board reporting |
| Bermuda PIPA | Organizations processing personal information in Bermuda | Personal data discovery, purpose-based access, retention, breach response |